Skip to main content
. Author manuscript; available in PMC: 2013 Sep 26.
Published in final edited form as: Pharmacogenet Genomics. 2013 Mar;23(3):156–166. doi: 10.1097/FPC.0b013e32835dc133

Fig. 1.

Fig. 1

SNP selection for association analysis. The flow chart outlines the selection criteria for SNPs used for the genotyping and association studies. Genome-wide SNPs are FKBP5 eQTLs. *SNP level quality control. SNPs selected for an association analysis had to meet the quality control measures: minor allele frequency >0.01, per SNP call rate>0.95, and Hardy–Weinberg equilibrium P-value>0.001. eQTLs, expression Quantitative Trait Locus; GWAS, genome-wide association study; LCLs, lymphoblastoid cell lines; MAF, minor allele frequency; Mayo PGRN, Mayo Clinic Pharmacogenomics Research Network; SNPs, single nucleotide polymorphisms.